Iris Wu Email and Phone Number
Zhejiang Huode Biotechnology Co., Ltd. (Hopstem) was established in Hangzhou in January 2017 by a group of neuroscience and stem cell scientists of Johns Hopkins University. Hopstem has established world-leading human iPSCs/ESCs neural differentiation and cell engineering technology platform and finished serial A financing.The company has 1,400 square meters of GLP/GMP cell manufactory and R&D center in Hangzhou. Hopstem provides high-quality human cells, reagents and services, including various types of human neural cells, 3D brain organoids, maturation medium and gene editing, etc. These human cells and organoids can be used as disease models or material for research, drug screening and toxicity tests. Hopstem Biotechnology aims to develop the most advanced cell therapies for neurological diseases, including human neuronal precursor cells for treatment of stroke, traumatic brain injury, cerebral palsy and other pipelines.
Hopstem Biotechnology Co., Ltd.
View- Website:
- hopstem.com
- Employees:
- 5
-
Commerce SpecialistHopstem Biotechnology Co., Ltd. Apr 2019 - PresentHangzhou, Zhejiang, China
Iris Wu Education Details
Frequently Asked Questions about Iris Wu
What company does Iris Wu work for?
Iris Wu works for Hopstem Biotechnology Co., Ltd.
What is Iris Wu's role at the current company?
Iris Wu's current role is Commerce Specialist at Hopstem Biotechnology Co., Ltd..
What schools did Iris Wu attend?
Iris Wu attended Quanzhou Normal University.
Who are Iris Wu's colleagues?
Iris Wu's colleagues are Anxin Wang.
Not the Iris Wu you were looking for?
-
1hotmail.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial